摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-联苯基甲醇 | 2928-43-0

中文名称
2-联苯基甲醇
中文别名
2-苯基苄醇;2-羟甲基联苯;2-联苯甲醇
英文名称
2-biphenylmethanol
英文别名
o-phenylbenzyl alcohol;2-phenylbenzyl alcohol;(2-phenylphenyl)methanol
2-联苯基甲醇化学式
CAS
2928-43-0
化学式
C13H12O
mdl
MFCD00004620
分子量
184.238
InChiKey
VKTQADPEPIVMHK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    46-48 °C (lit.)
  • 沸点:
    96 °C/0.04 mmHg (lit.)
  • 密度:
    1.0120 (rough estimate)
  • 闪点:
    >230 °F
  • 溶解度:
    可溶于氯仿(少许)、甲醇(少许)
  • 稳定性/保质期:

    遵照规定使用和储存,则不会分解。

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.076
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

安全信息

  • 危险品标志:
    Xn
  • 安全说明:
    S22,S24/25
  • 危险类别码:
    R20/21/22
  • WGK Germany:
    3
  • 海关编码:
    2906299090
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H302
  • 储存条件:
    存放于阴凉干燥处

SDS

SDS:ed0552f0905df8f11b98b24815b620b0
查看
Name: 2-Biphenylmethanol 98% Material Safety Data Sheet
Synonym: None
CAS: 2928-43-0
Section 1 - Chemical Product MSDS Name:2-Biphenylmethanol 98% Material Safety Data Sheet
Synonym:None

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
2928-43-0 2-biphenylmethanol 98.0 220-892-7
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Antidote: None reported.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal. Avoid generating dusty conditions. Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Keep container closed when not in use. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 2928-43-0: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystalline powder
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 96 deg C @ .04mm Hg
Freezing/Melting Point: 46.00 - 48.00 deg C
Autoignition Temperature: Not available.
Flash Point: > 112 deg C (> 233.60 deg F)
Explosion Limits, lower: N/A
Explosion Limits, upper: N/A
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C13H12O
Molecular Weight: 184.24

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents, acids, acid chlorides, acid anhydrides.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 2928-43-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-biphenylmethanol - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION
Other No information available.

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 2928-43-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 2928-43-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 2928-43-0 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    2-联苯基甲醇盐酸氧气10-甲基-9-均三甲苯基吖啶高氯酸盐 作用下, 以 1,3-二噁烷乙腈 为溶剂, 以57%的产率得到苯并[c]苯并吡喃-6-酮
    参考文献:
    名称:
    Visible light mediated oxidative lactonization of 2-methyl-1,1′-biaryls for the synthesis of benzocoumarins
    摘要:
    开发了一种可见光介导的2-甲基-1,1'-联苯基C-H内酯化反应,以氧氧化剂为氧化剂,产率较高地生成苯并香豆素。
    DOI:
    10.1039/c9ob00529c
  • 作为产物:
    描述:
    二氢-3-(异十二碳烯基)呋喃-2,5-二酮 在 lithium aluminium tetrahydride 作用下, 以 四氢呋喃 为溶剂, 反应 4.0h, 生成 2-联苯基甲醇
    参考文献:
    名称:
    通过Ru(II)催化的[3 + 2]环空和分子内Friedel-Crafts环化一锅法合成多取代的螺芴-茚
    摘要:
    Ru(II)通过[3 + 2]环化催化一锅法合成多取代的螺芴-茚,然后实现了分子内Friedel-Crafts烷基化。这种简单的方法提供了广泛的芳基酮和内部炔烃,以中等到良好的产率获得了PAHs骨架。
    DOI:
    10.1021/acs.joc.5b01517
点击查看最新优质反应信息

文献信息

  • A Bifunctional Copper Catalyst Enables Ester Reduction with H<sub>2</sub>: Expanding the Reactivity Space of Nucleophilic Copper Hydrides
    作者:Birte M. Zimmermann、Trung Tran Ngoc、Dimitrios-Ioannis Tzaras、Trinadh Kaicharla、Johannes F. Teichert
    DOI:10.1021/jacs.1c09626
    日期:2021.10.13
    activation of esters through hydrogen bonding and formation of nucleophilic copper(I) hydrides from H2, resulting in a catalytic hydride transfer to esters. The reduction step is further facilitated by a proton shuttle mediated by the guanidinium subunit. This bifunctional approach to ester reductions for the first time shifts the reactivity of generally considered “soft” copper(I) hydrides to previously
    采用基于 (I)/NHC 配合物和有机催化剂的双功能催化剂,促进了以 H 2作为末端还原剂的催化酯还原成醇。这里采用的方法能够通过氢键同时活化酯,并从 H 2形成亲核的氢化 (I) ,从而导致氢化物催化转移到酯。由亚基介导的质子穿梭进一步促进了还原步骤。这种酯还原的双功能方法首次将通常认为的“软”氢化 (I) 的反应性转变为以前不反应的“硬”酯亲电子试剂,并为用催化剂和 H 2替代化学计量还原剂铺平了道路.
  • Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
    申请人:CEPHALON, INC.
    公开号:EP1586559A1
    公开(公告)日:2005-10-19
    FIELD OF THE INVENTION The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions that include substituted biaryl-methanesulfinyl acetamides of Formula (I): wherein Ar, Y, R1, R2, R4, R5, q and x are as defined herein; and their use in the treatment of diseases, including treatment of sleepiness associated with narcolepsy, obstructive sleep apnea, or shift work disorder; Parkinson's disease; Alzheimer's disease; attention deficit disorder; attention deficit hyperactivity disorder; depression; or fatigue associated with a neurological disease; as well as the promotion of wakefulness.
    本发明涉及化学组合物、其制备方法以及组合物的用途。特别是,本发明涉及包括式(I)的取代联苯基-甲磺酰基乙酰胺的组合物: 其中Ar、Y、R1、R2、R4、R5、q和x如本文所定义;以及它们在治疗疾病中的用途,包括治疗与嗜睡症、阻塞性睡眠呼吸暂停或倒班工作障碍相关的嗜睡症、帕森病、阿尔茨海默病、注意力缺陷障碍、注意力缺陷多动障碍、抑郁症或与神经系统疾病相关的疲劳,以及促进清醒。
  • Water-soluble palladacycles containing hydroxymethyl groups: synthesis, crystal structures and use as catalysts for amination and Suzuki coupling of reactions
    作者:Xin Han、Hong-Mei Li、Chen Xu、Zhi-Qiang Xiao、Zhi-Qiang Wang、Wei-Jun Fu、Xin-Qi Hao、Mao-Ping Song
    DOI:10.1007/s11243-016-0036-5
    日期:2016.5
    2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl(Sphos)]-palladacycles containing hydroxymethyl groups 2–3 were prepared by cyclopalladation and chloride bridge-splitting reactions. The complexes were characterized by elemental analysis, ESI–MS and NMR. In addition, single-crystal X-ray analysis reveals that they have one-dimensional lamellar structures involving intermolecular hydrogen bonds and π–π interactions
    通过环化和桥分裂反应制备了两种溶性单膦 [PPh3 和 2-二环己基膦基-2',6'-二甲氧基联苯 (Sphos)]-含羟甲基 2-3 的环。通过元素分析、ESI-MS 和核磁共振对配合物进行表征。此外,单晶X射线分析表明它们具有涉及分子间氢键和π-π相互作用的一维层状结构。研究了使用这些环作为芳基中胺化和 Suzuki 偶联的催化剂。发现配合物 3 对于这些偶联反应非常有效。此外,它还成功地用于(羟甲基)苯基硼酸的 Suzuki 偶联,以合成取代的 2-N-杂环联芳甲醇
  • Synthesis, in Vitro Pharmacology, Structure−Activity Relationships, and Pharmacokinetics of 3-Alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Derivatives as Potent and Selective Group II Metabotropic Glutamate Receptor Antagonists
    作者:Atsuro Nakazato、Kazunari Sakagami、Akito Yasuhara、Hiroshi Ohta、Ryoko Yoshikawa、Manabu Itoh、Masato Nakamura、Shigeyuki Chaki
    DOI:10.1021/jm0400294
    日期:2004.8.1
    Novel group II metabotropic glutamate receptor (mGluR) antagonists, 3-alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives 11 and 12, were discovered by the incorporation of a hydroxy or alkoxyl group onto the C-3 portion of selective and potent group II mGluR agonist 5, (1R,2S,5R,6R)-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid. Among these compounds, (1R,2R
    通过掺入羟基或烷氧基,发现了新型的II类代谢型谷酸受体(mGluR)拮抗剂3-烷氧基-2-基-6-双环[3.1.0]己烷-2,6-二羧酸生物11和12。在选择性和有效的第II组mGluR激动剂5(1R,2S,5R,6R)-2-基-6-双环[3.1.0]己烷-2,6-二羧酸的C-3部分上连接基团 在这些化合物中,(1R,2R,3R,5R,6R)-2-基-3-(3,4-二苄氧基)-6-双环[3.1.0]己烷-2,6-二羧酸(-)- 11be(MGS0039)是一种具有最佳药代动力学特征的高选择性强效II组mGluR拮抗剂。化合物(-)-11对mGlu 2(Ki = 2.38 +/- 0.40 nM)和mGlu 3(4.46 +/- 0.31 nM)表现出高亲和力,但对mGluR 7(Ki = 664 +/- 106 nM)的亲和力低,和有效的mGlu 2拮抗剂活性(IC50 =
  • Lewis Base-Promoted Ring-Opening 1,3-Dioxygenation of Unactivated Cyclopropanes Using a Hypervalent Iodine Reagent
    作者:Matthew H. Gieuw、Zhihai Ke、Ying-Yeung Yeung
    DOI:10.1002/anie.201713422
    日期:2018.3.26
    A facile and effective system has been developed for the regio‐ and chemoselective ring‐opening/electrophilic functionalization of cyclopropanes through C−C bond activation by [bis(trifluoroacetoxy)iodo]benzene with the aid of the Lewis basic promoter p‐toluenesulfonamide. The p‐toluenesulfonamide‐promoted system works well for a wide range of cyclopropanes, resulting in the formation of 1,3‐diol products
    已经开发了一种简便有效的系统,借助路易斯(Lewis)碱性促进剂甲苯磺酰胺,通过[双(三氟乙酰氧基)]苯的CC键活化,对环丙烷的区域和化学选择性开环/亲电子官能化。所述p -toluenesulfonamide促进的系统可以很好地用于宽范围的环丙烷,得到1,3-二醇产物以良好产率选择性和区域选择性的形成。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
hnmr
mass
cnmr
ir
raman
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫